Application | Comment | Organism |
---|---|---|
drug development | synergistic inhibition of the enzyme by disulfiram and 6-thioguanine or mycophenolic acid implies the potential for combination treatments using these three clinically available drugs | Middle East respiratory syndrome-related coronavirus |
Crystallization (Comment) | Organism |
---|---|
crystals of SARS-CoV PLpro in complex with 2-mercaptoethanol or glycerol are obtained at 22°C by the sitting-drop vapor-diffusion method | Severe acute respiratory syndrome-related coronavirus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Disulfiram | allosteric inhibition. Synergistic inhibition of the enzyme by disulfiram and 6-thioguanine or mycophenolic acid implies the potential for combination treatments using these three clinically available drugs | Middle East respiratory syndrome-related coronavirus | |
Disulfiram | slow-binding inhibition and the irrecoverability of enzyme activity after removing unbound disulfiram indicates covalent inactivation. Disulfiram may act at the active site of the enzyme, forming a covalent adduct with residue Cys112. Competitive (or mixed) inhibitor | Severe acute respiratory syndrome-related coronavirus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0195 | - |
Dabcyl-FRLKGGAPIKGV-Edans | pH 6.5, 30°C, wild-type enzyme | Severe acute respiratory syndrome-related coronavirus | |
0.0246 | - |
Dabcyl-FRLKGGAPIKGV-Edans | pH 6.5, 30°C, mutant enzyme C271A | Severe acute respiratory syndrome-related coronavirus | |
0.0288 | - |
Dabcyl-FRLKGGAPIKGV-Edans | pH 6.5, 30°C, wild-type enzyme | Middle East respiratory syndrome-related coronavirus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Middle East respiratory syndrome-related coronavirus | - |
MERS-CoV | - |
Severe acute respiratory syndrome-related coronavirus | P0C6X7 | replicase polyprotein 1ab; human, i.e. SARS-CoV | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Dabcyl-FRLKGGAPIKGV-Edans + H2O | - |
Severe acute respiratory syndrome-related coronavirus | ? | - |
? | |
Dabcyl-FRLKGGAPIKGV-Edans + H2O | - |
Middle East respiratory syndrome-related coronavirus | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
MERS coronavirus papain-like protease | - |
Middle East respiratory syndrome-related coronavirus |
SARS coronavirus papain-like protease | - |
Severe acute respiratory syndrome-related coronavirus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
30 | - |
assay at | Severe acute respiratory syndrome-related coronavirus |
30 | - |
assay at | Middle East respiratory syndrome-related coronavirus |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.01 | - |
Dabcyl-FRLKGGAPIKGV-Edans | pH 6.5, 30°C, wild-type enzyme | Middle East respiratory syndrome-related coronavirus | |
0.12 | - |
Dabcyl-FRLKGGAPIKGV-Edans | pH 6.5, 30°C, mutant enzyme C271A | Severe acute respiratory syndrome-related coronavirus | |
0.18 | - |
Dabcyl-FRLKGGAPIKGV-Edans | pH 6.5, 30°C, wild-type enzyme | Severe acute respiratory syndrome-related coronavirus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6.5 | - |
assay at | Severe acute respiratory syndrome-related coronavirus |
6.5 | - |
assay at | Middle East respiratory syndrome-related coronavirus |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.004 | - |
Disulfiram | pH 6.5, 30°C, wild-type enzyme, determined in accordance with competitive inhibition | Severe acute respiratory syndrome-related coronavirus | |
0.0201 | - |
Disulfiram | pH 6.5, 30°C | Middle East respiratory syndrome-related coronavirus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0044 | - |
pH 6.5, 30°C, with 0.015 mM 6-thioguanine and 0.15 mycophenolic acid, wild-type enzyme | Middle East respiratory syndrome-related coronavirus | Disulfiram | |
0.0142 | - |
pH 6.5, 30°C, wild-type enzyme | Severe acute respiratory syndrome-related coronavirus | Disulfiram | |
0.0181 | - |
pH 6.5, 30°C, with 0.004 mM N-ethylmaleimide, wild-type enzyme | Severe acute respiratory syndrome-related coronavirus | Disulfiram | |
0.0218 | - |
pH 6.5, 30°C, with 0.015 mM 6-thioguanine, wild-type enzyme | Severe acute respiratory syndrome-related coronavirus | Disulfiram | |
0.0627 | - |
pH 6.5, 30°C, mutant enzyme C271A | Severe acute respiratory syndrome-related coronavirus | Disulfiram | |
0.137 | - |
pH 6.5, 30°C, with 0.01 mM 6-thioguanine and 0.1 mycophenolic acid, wild-type enzyme | Middle East respiratory syndrome-related coronavirus | Disulfiram | |
0.145 | - |
pH 6.5, 30°C, with 0.015 mM 6-thioguanine, wild-type enzyme | Middle East respiratory syndrome-related coronavirus | Disulfiram | |
0.217 | - |
pH 6.5, 30°C, with 0.15 mycophenolic acid, wild-type enzyme | Middle East respiratory syndrome-related coronavirus | Disulfiram | |
0.227 | - |
pH 6.5, 30°C, wild-type enzyme | Middle East respiratory syndrome-related coronavirus | Disulfiram |